ReviewFrontiers in pharmacology2021

Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia.

Meike Kaehler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.